Will Regeneron's hantavirus monoclonal antibody enter Phase 2 by October 1?
Regeneron's REGN-COV2 antibody cocktail received EUA in Nov 2020. Their monoclonal antibody platform could be redirected to hantavirus. Phase 2 by October would indicate rapid development.
Resolves YES if ClinicalTrials.gov shows a Regeneron-sponsored hantavirus monoclonal antibody registered as Phase 2 with first patient enrolled before 2026-10-01.
On settlement the oracle attaches a signed snapshot of each source URL plus a SHA-256 hash of the page content captured at resolution time. Disputes have a 7-day arbitration window.
cited: ClinicalTrials.gov + Regeneron press releases
Resolution sources · 3
v2 API returns JSON. Resolves the vaccine-Phase-2 market. Filter `statusModule.overallStatus` and `phase`.
Wire-grade source; resolves the NYT/major-media markets.
Cheap sentiment + earliest-mover for translated regional press. Run a dedup hash on titles + canonical URL.
ETL workers poll these feeds and merge into the resolution oracle.full registry